ArticleJournal of clinical medicine2024

The Evaluation of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in Different Therapy Lines for Metastatic Melanoma: A Retrospective Study.

Saki Okuda-Hiwatashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.